Similar Articles
341 Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
342 Can DKI-MRI predict recurrence and invasion of peritumoral zone of hepatocellular carcinoma after transcatheter arterial chemoembolization?
343 Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria
344 Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma
345 Three-in-one incidence of hepatocellular carcinoma, cholangiocellular carcinoma, and neuroendocrine carcinoma: A case report
346 Elevated procalcitonin levels in the absence of infection in procalcitonin-secretin hepatocellular carcinoma: A case report
347 VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
348 Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
349 Multiple primary malignancies – hepatocellular carcinoma combined with splenic lymphoma: A case report
350 Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA